Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027

Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027

The Global Ophthalmoscopes market is expected to grow at a CAGR of 5.69% during 2022-2027

The following factors are likely to contribute to the global ophthalmoscope market growth during the forecast period:

  • Raising Awareness Among Patients Population by Increasing the Eye Care Services in Developed Countries
  • Increasing Eye Disorders Prevalence & Surgical Procedures
  • Surging Prevalence of Eye Disorders Patient Population
  • Increasing Government Initiative for Eye Care
Ophthalmoscope (Fundoscopy) is a medical device used to perform ophthalmoscopy to understand the health of vitreous humor, optic disc, & retina of the eye. So, ophthalmoscopy is the most vital part of eye examination and is used to detect the symptoms of retinal vascular diseases such as cataracts, glaucoma, diabetic retinopathy, and age macular degeneration. It involves eye checkups for patients who suffer from diabetes mellitus conditions in which ophthalmoscopy plays a vital role in routinely monitoring the diabetic retinopathy condition.

The rising prevalence of eye diseases is driving the growth of the eye testing equipment market. Around 596 million people are suffering from distance vision impairment globally, of which 43 million people are blind. Approximately 510 million patients, on the other hand, had uncorrected near vision impairment. Most of these populations live in low-middle-income countries, accounting for 90% of cases. Around 895 million people will be suffering from distance vision impairment by 2050, and 61 million be blind. The increasing target population offers high growth opportunities to the players.

OPHTHALMOSCOPES MARKET TRENDS

Technological innovations and advanced products will further optimize the usage of ophthalmoscope devices in the industry. Scanning laser ophthalmoscopes have been available in the market since the 1990s, but recently increasing popularity and plenty of advantages delivery gives new direction to the industry. Currently, scanning laser ophthalmoscopes improved significantly. These ophthalmoscopes can obtain images with broader views of the ocular fundus with maintaining high resolution and increasing the application rate in eye examinations. These are superior in conventional fundoscopy with their ability to image abnormal alteration of choroid and retina.

On the other side, indirect laser ophthalmoscopy, smartphone base indirect ophthalmoscope, and vision boost technology are some innovations that are revolutionizing the industry. Also, the rising application of ophthalmoscopes in other medical fields such as neurology and headache treatment will create new opportunities in the upcoming time.

VENDOR ANALYSIS
  • In 2021, Heine launched a new indirect ophthalmoscope with the product Omega600. By introducing new products, the company made a significant change in the market with vision boost technology to increase the illumination and increase the clinician's capability to test the patient's cataract condition and vitreous opacities.
  • In 2021, the BMJ journal reported that the smartphone ophthalmoscopy technology has a potential way in the covid-19 era for non-ophthalmology medicine. Smartphone ophthalmoscope has generally accounted for more favorably than direct handling time. This device gives the practitioners the capacity of long-distance working to examine and view the fundus from around arm's length compared to the general Ophthalmoscope.
  • In 2021, the Hillrom company introduced the Welch Allyn PanOptic Plus Ophthalmoscope devices that boast a 20X larger viewing area.
Key Players
  • Heine USA Ltd
  • Dino Lite Europe
  • Iridex Corporation
  • Halma
  • Nidek Co. Ltd.
  • Oscar Boscarol S.r.l
  • Rudolf Riester GmbH
  • US Ophthalmic
Other Prominent Vendors
  • Albert Waeschle
  • American Diagnostic Corporation
  • Shanghai Bolan Optical Electric Co Ltd
  • Carl Zeiss
  • Ellex
  • Essilor International (Essilor Instruments USA)
  • Heidelberg Engineering
  • Invotech Excel
  • Medline Industries LP
  • Neitz Instruments Co Ltd
  • Suzhou Kangjie Medical Inc
  • Spengler
  • Topcon Co. Ltd
  • Lumenis
  • Zumax Medical
  • 66 Vision Tech
  • Zhejiang Honsun Medical Technologies Co. Ltd
MARKET DRIVERS

Manufacturers' enhanced efforts to promote awareness about developments in ophthalmoscope technology are driving the global ophthalmoscopes market expansion. Furthermore, rising healthcare expenditures for the treatment of vision loss, blindness, and sight-threatening disorders are predicted to boost demand for primary eye care and examinations, hence, increasing the demand for critical equipment such as ophthalmoscopes over the forecast period. On the other side increasing prevalence of eye diseases influence the need for eye examination and drives the high growth of ophthalmoscopes applications. Cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration are the primary eye condition that requires ophthalmoscopes.

The increasing prevalence of the above conditions and excellent access to eye care services in developed countries positively triggered the application rate of ophthalmoscopes. Rising prevalence led to an eye examination and its demand for the ophthalmoscopy for diabetes retinopathy, cataract, glaucoma, corneal opacities, and other eye conditions.

SEGMENTATION ANALYSIS
  • The Ophthalmoscopes market is segmented into direct & indirect ophthalmoscopes. Welch Allyn, Nidek Inc, Heine USA Ltd., US ophthalmic, Honsun Group, Iridex Corporation, Oscar Boscarlol S.r.l., Zumax Medical Co. Ltd, Rudolf Riester GmbH, Dino-Lite Europe, Medline Industries Inc. are some of the biggest direct ophthalmoscope manufacturing businesses.
  • In 2021, direct Ophthalmoscopes accounted for 60.16% of the industry share and stood in prime position.
  • Nidek Co. Inc, Ellex Medical Laser Ltd, Carls Zeiss, Ziemer Ophthalmic System Ag, Keeler Ltd, Heine Optotechnik GmbH, Topcon Medical Laser System, Iridex Corporation, Lumenis Ltd, and others are among the leading manufacturers of indirect ophthalmoscopes.
  • The wide presence of players with a broad range of product portfolios gives a dynamic nature to the industry. A high number of market players and their global distribution channels increased the market growth.
  • The indication market is segmented into glaucoma, diabetic retinopathy, retinal detachment, age-related macular degeneration, cataracts, macular pucker, corneal opacities, trachoetc ma, presbyopia, myopia, astigmatism, peripheral neovascularization, lattice degeneration, etc.) eye diseases. The glaucoma segment accounted for 31.81% market share in 2021 and dominated the other indications. Diabetic retinopathy accounted for 23.37% of market share, age-related macular degeneration segmented accounted for 18.03% market share, and retinal detachment accounted for 5.27% of industry share in 2021.
  • End-user is segmented into eye clinics and Hospitals, ophthalmologists & optometrists, and ambulatory surgical centers. The wise presence of eye clinics and hospitals drives the high application rate of ophthalmoscopes for eye testing. In 2021, the eye clinics and hospitals segment accounted for 52.34% market share and dominated the other end-user segment. On the other side, ophthalmologists, optometrist segments, and ambulatory surgical centers accounted for 32.80% and 14.86% industry share. Ambulatory surgical centers are the most widely accepted eye care service, which consistently influenced the industry's growth.
Segmentation by Type
  • Direct
  • Indirect
Segmentation by Indication
  • Glaucoma
  • Diabetic Retinopathy
  • Age-Related Macular Degeneration
  • Retinal Detachment
  • Other
Segmentation by End-User
  • Eye Clinics & Hospitals
  • Ophthalmologist & Optometrist
  • Ambulatory Surgical Centres
GEOGRAPHICAL ANALYSIS
  • Eye care services are widely available in North America. The high prevalence of eye conditions, greater access to an eye examination, and high awareness drive the high application rate of ophthalmoscope medical devices. Also, the presence of ophthalmoscope market players significantly improved the growth in North America, with a 38.82% share in 2021.
  • Europe region stands in the second position with 32.89% market share. In 2021, Europe accounted for around USD 17.44 million and was expected to reach USD 24.34 million by 2027, growing at a CAGR of 5.71% during the forecast period. The increasing frequency of diabetic retinopathy, glaucoma, and cataracts prompted a high rate of ophthalmoscope use in eye care services, which fueled the market growth.
  • APAC region is home to diabetes conditions that drive the Ophthalmoscope to identify diabetic retinopathy. On the other side, a dense population and an aging population positively drive market growth in the region, accounting for 20.23% market share.
  • Latin America is an emerging market with increasing eye care expenditure, a rising patient population, and growing demand for eye care services. In 2021, Latin America accounted for 5.04% market share 2021.
  • Middle East & Africa is one of the major regions with significant growth opportunities for market growth. A high number of glaucoma, diabetic retinopathy, and blindness patients population and increasing government initiatives are the most common factors triggering the market growth in the region. In 2021, Middle East & Africa accounted for a 3.01% market share in the global ophthalmoscope market.
Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia
KEY QUESTIONS ANSWERED

1. How Big is the Ophthalmoscopes Market?

2. What are the Latest Trends in The Ophthalmoscopes Market?

3. Who are the Key Players in The Ophthalmoscopes Market?

4. What are the Growth Enablers in The Ophthalmoscopes Market?

5. Which End-User Segment to Hold the Largest Share In The Ophthalmoscope Market By 2027?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TYPE
4.3.2 MARKET SEGMENTATION BY INDICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCES & NEW APPLICATIONS OF OPHTHALMOSCOPES
8.2 GOVERNMENT’S EYE CARE INITIATIVES
8.3 HIGHER GROWTH OPPORTUNITIES IN EMERGING MARKETS
9 MARKET GROWTH ENABLERS
9.1 RISE IN AWARENESS OF EYE CARE SERVICES IN DEVELOPED COUNTRIES
9.2 RISE IN EYE DISORDER PREVALENCE & SURGICAL PROCEDURES
9.3 ADVENT OF ADVANCED OPHTHALMOSCOPES
9.4 INCREASE IN PATIENT POPULATION WITH EYE DISORDERS
10 MARKET RESTRAINTS
10.1 LACK OF EYE CARE SERVICES IN EMERGING MARKETS
10.2 INSUFFICIENT OPHTHALMOLOGISTS IN DEVELOPING COUNTRIES
10.3 STRINGENT REGULATIONS & PRODUCT RECALLS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 INSIGHTS BY GEOGRAPHY
11.2.2 INSIGHTS BY TYPE
11.2.3 INSIGHTS BY INDICATION
11.2.4 INSIGHTS BY END-USER
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 TYPE
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 DIRECT OPHTHALMOSCOPE
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 MARKET BY GEOGRAPHY
12.4 INDIRECT OPHTHALMOSCOPE
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 MARKET BY GEOGRAPHY
13 INDICATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 GLAUCOMA
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 DIABETIC RETINOPATHY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 AGE-RELATED MACULAR DEGENERATION
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 RETINAL DETACHMENT
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 OTHERS
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 EYE CLINICS & HOSPITALS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 OPHTHALMOLOGISTS AND OPTOMETRISTS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 AMBULATORY SURGICAL CENTERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 TYPE
16.3.1 MARKET SIZE & FORECAST
16.4 INDICATION
16.4.1 MARKET SIZE & FORECAST
16.5 END-USER
16.5.1 MARKET SIZE & FORECAST
16.6 KEY COUNTRIES
16.6.1 US: MARKET SIZE & FORECAST
16.6.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TYPE
17.3.1 MARKET SIZE & FORECAST
17.4 INDICATION
17.4.1 MARKET SIZE & FORECAST
17.5 END-USER
17.5.1 MARKET SIZE & FORECAST
17.6 KEY COUNTRIES
17.6.1 GERMANY: MARKET SIZE & FORECAST
17.6.2 FRANCE: MARKET SIZE & FORECAST
17.6.3 UK: MARKET SIZE & FORECAST
17.6.4 ITALY: MARKET SIZE & FORECAST
17.6.5 SPAIN: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 INDICATION
18.4.1 MARKET SIZE & FORECAST
18.5 END-USER
18.5.1 MARKET SIZE & FORECAST
18.6 KEY COUNTRIES
18.6.1 JAPAN: MARKET SIZE & FORECAST
18.6.2 CHINA: MARKET SIZE & FORECAST
18.6.3 INDIA: MARKET SIZE & FORECAST
18.6.4 AUSTRALIA: MARKET SIZE & FORECAST
18.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 INDICATION
19.4.1 MARKET SIZE & FORECAST
19.5 END-USER
19.5.1 MARKET SIZE & FORECAST
19.6 KEY COUNTRIES
19.6.1 BRAZIL: MARKET SIZE & FORECAST
19.6.2 MEXICO: MARKET SIZE & FORECAST
19.6.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 INDICATION
20.4.1 MARKET SIZE & FORECAST
20.5 END-USER
20.5.1 MARKET SIZE & FORECAST
20.6 KEY COUNTRIES
20.6.1 TURKEY: MARKET SIZE & FORECAST
20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
22 KEY COMPANY PROFILES
22.1 HEINE
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.1.3 KEY STRATEGIES
22.1.4 KEY STRENGTHS
22.1.5 KEY OPPORTUNITIES
22.2 DINO-LITE EUROPE (ANMO ELECTRONICS CORPORATION)
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.2.3 KEY STRATEGIES
22.2.4 KEY STRENGTHS
22.2.5 KEY OPPORTUNITIES
22.3 IRIDEX
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.3.3 KEY STRATEGIES
22.3.4 KEY STRENGTHS
22.3.5 KEY OPPORTUNITIES
22.4 HALMA
22.4.1 BUSINESS OVERVIEW
22.4.2 PRODUCT OFFERINGS
22.4.3 KEY STRATEGIES
22.4.4 KEY STRENGTHS
22.4.5 KEY OPPORTUNITIES
22.5 NIDEK
22.5.1 BUSINESS OVERVIEW
22.5.2 PRODUCT OFFERINGS
22.5.3 KEY STRATEGIES
22.5.4 KEY STRENGTHS
22.5.5 KEY OPPORTUNITY
22.6 OSCAR BOSCAROL
22.6.1 BUSINESS OVERVIEW
22.6.2 PRODUCT OFFERINGS
22.6.3 KEY STRATEGIES
22.6.4 KEY STRATEGIES
22.6.5 KEY OPPORTUNITIES
22.7 RUDOLF RIESTER
22.7.1 BUSINESS OVERVIEW
22.7.2 PRODUCT OFFERINGS
22.7.3 KEY STRATEGIES
22.7.4 KEY STRENGTHS
22.7.5 KEY OPPORTUNITIES
22.8 WELCH ALLYN (HILL ROM)
22.8.1 BUSINESS OVERVIEW
22.8.2 PRODUCT OFFERINGS
22.8.3 KEY STRATEGIES
22.8.4 KEY STRENGTHS
22.8.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 ALBERT WAESCHLE
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 AMERICAN DIAGNOSTIC CORPORATION
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 SHANGHAI BOLAN OPTICAL ELECTRIC
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 CARL ZEISS
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 LUMIBIRD GROUP (ELLEX)
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERING
23.6 ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA)
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERING
23.7 HEIDELBERG ENGINEERING
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 INVOTECH EXCEL
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERINGS
23.9 MEDLINE INDUSTRIES
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 NEITZ INSTRUMENTS
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 SUZHOU KANGJIE MEDICAL
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 SPENGLER HOLTEX GROUP
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 TOPCON
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
23.14 LUMENIS
23.14.1 BUSINESS OVERVIEW
23.14.2 PRODUCT OFFERINGS
23.15 ZUMAX MEDICAL CO. LTD
23.15.1 BUSINESS OVERVIEW
23.15.2 PRODUCT OFFERINGS
23.16 66 VISION TECH
23.16.1 BUSINESS OVERVIEW
23.16.2 PRODUCT OFFERINGS
23.17 ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD
23.17.1 BUSINESS OVERVIEW
23.17.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 GEOGRAPHY
25.2 TYPE
25.3 INDICATION
25.4 END-USER
25.5 TYPE (GEOGRAPHICAL DISTRIBUTION)
25.5.1 DIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY
25.5.2 INDIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY
25.6 INDICATION (GEOGRAPHICAL DISTRIBUTION)
25.6.1 GLAUCOMA: MARKET BY GEOGRAPHY
25.6.2 DIABETIC RETINOPATHY: MARKET BY GEOGRAPHY
25.6.3 AGE-RELATED MACULAR DEGENERATION: MARKET BY GEOGRAPHY
25.6.4 RETINAL DETACHMENT: MARKET BY GEOGRAPHY
25.6.5 OTHERS: MARKET BY GEOGRAPHY
25.7 END-USER (GEOGRAPHICAL DISTRIBUTION)
25.7.1 EYE CLINICS & HOSPITALS: MARKET BY GEOGRAPHY
25.7.2 OPHTHALMOLOGISTS & OPTOMETRISTS: MARKET BY GEOGRAPHY
25.7.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY
26 APPENDIX
26.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings